Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2018 Update

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME791PD
  • |
  • Pages: 51
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in the Americas, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Anika Therapeutics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Anika Therapeutics Inc Company Overview 6

Anika Therapeutics Inc Company Snapshot 6

Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Anika Therapeutics Inc-Pipeline Analysis Overview 9

Business Description 9

Anika Therapeutics Inc-Key Facts 9

Anika Therapeutics Inc-Major Products and Services 10

Anika Therapeutics Inc Pipeline Products by Development Stage 12

Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 14

Anika Therapeutics Inc Pipeline Products Overview 16

Cingal 16

Cingal Product Overview 16

Drug Delivery System 17

Drug Delivery System Product Overview 17

Hemostatic Patch 18

Hemostatic Patch Product Overview 18

HYAFF-Rotator Cuff Repair 19

HYAFF-Rotator Cuff Repair Product Overview 19

HYAFF Barrier Film 20

HYAFF Barrier Film Product Overview 20

HYAFF Gel 21

HYAFF Gel Product Overview 21

HYAFF Mesh 22

HYAFF Mesh Product Overview 22

Hyalobone 23

Hyalobone Product Overview 23

Hyalofast 24

Hyalofast Product Overview 24

Hyalofast Clinical Trial 25

Hyaloglide 26

Hyaloglide Product Overview 26

Hyalograft C Autograft 27

Hyalograft C Autograft Product Overview 27

Hyalonect 28

Hyalonect Product Overview 28

Hyaluronic Acid-Synovial Joints 29

Hyaluronic Acid-Synovial Joints Product Overview 29


MONOVISC Product Overview 30


MONOVISC-Hip Product Overview 31

MONOVISC-Hip Clinical Trial 32

Next Generation ELEVESS Dermal Filler 33

Next Generation ELEVESS Dermal Filler Product Overview 33


ORTHOVISC-T Product Overview 34

SCS 17-01 35

SCS 17-01 Product Overview 35

Anika Therapeutics Inc-Key Competitors 36

Anika Therapeutics Inc-Key Employees 37

Anika Therapeutics Inc-Key Employee Biographies 38

Anika Therapeutics Inc-Locations And Subsidiaries 39

Head Office 39

Other Locations & Subsidiaries 39

Recent Developments 40

Anika Therapeutics Inc, Recent Developments 40

Jun 19, 2018: Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis 40

May 08, 2018: Anika to Showcase Commercial and Pipeline Portfolio at 18th Bi-Annual European Society for Sports Traumatology, Knee Surgery and Arthroscopy Congress 40

May 02, 2018: Anika Reports First Quarter 2018 Financial Results 41

Apr 24, 2018: Amplify What's Possible: Medline to Highlight Holistic Approach to Wound Care and Skin Health at Symposium on Advanced Wound Care 42

Apr 06, 2018: Anika Announces Plans to Showcase HYALOFAST Hyaluronic Acid-Based Scaffold at the 2018 World Congress of the International Cartilage Repair Society 43

Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director 44

Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results 45

Dec 27, 2017: Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment 45

Oct 25, 2017: Anika Reports Third Quarter 2017 Financial Results 46

Oct 23, 2017: Anika Announces the Forthcoming Appointment of Thomas M. Finnerty as Chief Human Resources Officer 47

Appendix 48

Methodology 48

About GlobalData 51

Contact Us 51

Disclaimer 51

List of Figures

Anika Therapeutics Inc Pipeline Products by Equipment Type 7

Anika Therapeutics Inc Pipeline Products by Development Stage 12

Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 14

List of Tables

Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Anika Therapeutics Inc Pipeline Products by Equipment Type 7

Anika Therapeutics Inc Pipeline Products by Indication 8

Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 8

Anika Therapeutics Inc, Key Facts 9

Anika Therapeutics Inc, Major Products and Services 10

Anika Therapeutics Inc Number of Pipeline Products by Development Stage 12

Anika Therapeutics Inc Pipeline Products Summary by Development Stage 13

Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 14

Anika Therapeutics Inc Ongoing Clinical Trials Summary 15

Cingal-Product Status 16

Cingal-Product Description 16

Drug Delivery System-Product Status 17

Drug Delivery System-Product Description 17

Hemostatic Patch-Product Status 18

Hemostatic Patch-Product Description 18

HYAFF-Rotator Cuff Repair-Product Status 19

HYAFF-Rotator Cuff Repair-Product Description 19

HYAFF Barrier Film-Product Status 20

HYAFF Barrier Film-Product Description 20

HYAFF Gel-Product Status 21

HYAFF Gel-Product Description 21

HYAFF Mesh-Product Status 22

HYAFF Mesh-Product Description 22

Hyalobone-Product Status 23

Hyalobone-Product Description 23

Hyalofast-Product Status 24

Hyalofast-Product Description 24

Hyalofast-A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control 25

Hyaloglide-Product Status 26

Hyaloglide-Product Description 26

Hyalograft C Autograft-Product Status 27

Hyalograft C Autograft-Product Description 27

Hyalonect-Product Status 28

Hyalonect-Product Description 28

Hyaluronic Acid-Synovial Joints-Product Status 29

Hyaluronic Acid-Synovial Joints-Product Description 29

MONOVISC-Product Status 30

MONOVISC-Product Description 30

MONOVISC-Hip-Product Status 31

MONOVISC-Hip-Product Description 31

MONOVISC-Hip-Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip 32

Next Generation ELEVESS Dermal Filler-Product Status 33

Next Generation ELEVESS Dermal Filler-Product Description 33

ORTHOVISC-T-Product Status 34

ORTHOVISC-T-Product Description 34

SCS 17-01-Product Status 35

SCS 17-01-Product Description 35

Anika Therapeutics Inc, Key Employees 37

Anika Therapeutics Inc, Key Employee Biographies 38

Anika Therapeutics Inc, Subsidiaries 39

Glossary 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Vertical Spine, LLC

Repligen Corp

MiMedx Group Inc

Lattice Biologics Ltd

Citagenix Inc

Aziyo Biologics Inc

Anika Therapeutics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53228
Site License
USD 1500 INR 106455
Corporate User License
USD 2250 INR 159683



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]